Anterix (ATEX) Common Equity (2014 - 2025)

Anterix has reported Common Equity for 12 years, with the latest figure at $236.0 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 63.01% year-over-year to $236.0 million; the trailing twelve-month figure through Dec 2025 stood at $236.0 million (up 63.01% YoY), and the FY2025 full-year result was $156.6 million, down 2.75% from the prior year.
• Common Equity for Q4 2025 stood at $236.0 million, down from $240.3 million in the prior quarter.
• The five-year high for Common Equity was $240.3 million in Q3 2025, with the low at $139.1 million in Q3 2024.
• Historically, Common Equity has averaged $181.9 million across 5 years, with a median of $177.9 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity dropped 22.11% — and 2025, when it soared 72.83%.
• Anterix's Common Equity stood at $195.6 million in 2021, then fell by 18.71% to $159.0 million in 2022, then increased by 8.33% to $172.3 million in 2023, then fell by 15.97% to $144.7 million in 2024, then soared by 63.01% to $236.0 million in 2025.
• The last three Common Equity figures came in at $236.0 million (Q4 2025), $240.3 million (Q3 2025), and $184.8 million (Q2 2025), per Business Quant data.